• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Managing allergy-related COVID-19 vaccine hesitancy: A multi-methods analysis of practitioner notes and referral outcomes

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2025 Dec;21(1):2561457.
doi: 10.1080/21645515.2025.2561457. Epub 2025 Sep 16. Managing allergy-related COVID-19 vaccine hesitancy: A multi-methods analysis of practitioner notes and referral outcomes

Richard M Clarke[SUP] 1 [/SUP], Stephen P O'Hickey[SUP] 2 [/SUP], Elaine Walklet[SUP] 1 [/SUP], Eleanor Bradley[SUP] 3 [/SUP], Berenice Mahoney[SUP] 4 [/SUP]



Affiliations
Free article Abstract

This study examines healthcare practitioners' decision-making processes when managing vaccine-hesitant patients concerned about allergic reactions to COVID-19 vaccines. A multi-methods secondary data analysis was conducted combining quantitative referral trends and qualitative thematic analysis of health practitioner recorded notes. Anonymized data from 326 individuals referred to an interim COVID-19 vaccine allergy advice service based in Herefordshire and Worcestershire, UK, were analyzed. Quantitative data included referral patterns and vaccination outcomes, while qualitative data consisted of thematic analysis of free-text health practitioner notes documenting patient concerns and practitioner decision-making. Of the referred cases, 23.3% were advised to proceed with vaccination in primary care without precaution, 29% with additional precautions such as antihistamines and extended observation. Hospital-based vaccination was only recommended for 0.9%, typically for individuals with complex allergy histories. In 22.7%, cases were escalated to a multidisciplinary team that mainly advised vaccination in primary care with precautions or in hospital settings. Notably, no cases resulted in recommendations against vaccination. The qualitative analysis of health practitioner free text notes developed three themes: diverse presentation of allergies, complex allergy histories, and patient anxiety and lack of trust. Themes suggest healthcare practitioners face significant challenges in clinical decision-making with these patients and highlight the complexity of managing vaccine hesitancy. This study underscores the need for enhanced training and standardized documentation processes to support healthcare practitioners in managing allergy-related vaccine hesitancy. Public health messaging should proactively address misconceptions about vaccines as they relate to allergies, to build trust and reduce hesitancy.

Keywords: COVID-19 vaccination; Vaccine hesitancy; allergy; electronic health records; healthcare practitioner decision-making; mRNA vaccines.

 
Back
Top Bottom